Impact Stories: Augurex

Photo of Augurex’s new state-of-the-art labs

Innovative research.
Life-changing science.

Augurex is a biotech company that developed the JOINTstat® blood test to detect early signs of rheumatoid arthritis.

Used in Canada, the United States, Europe and Japan, Augurex’s innovation allows doctors to treat the disease early and lessen long-term joint damage in patients.

How we’re helping them grow their business

  • Wage subsidies to help hire post-doctoral employees
  • Funding to adapt technology for international markets
  • Financing and strategy development for international exports
  • Insurance funding for lab and office space
  • Federal and provincial funding and advisory services
  • Advice and funding to explore new commercial opportunities

How they’re helping
to build our economy

icon of 2 high-rise buildings

Fostering Innovation

icon of increasing graph with arrow

Growing Fast

icon of globe

Exporting Globally

icon of group of people

Creating Jobs

icon of hand holding a leaf

Increasing productivity

With the support of
AGS partners

  • Export Development Canada (EDC)
  • Business Development Bank of Canada (BDC)
  • Global Affairs Canada’s Going Global Program
  • Global Affairs Canada’s CanExport Program
  • National Research Council’s Industrial Research Assistance Program (NRC-IRAP)
  • Mitacs

Think you’re AGS ready?
Get in touch

Call us, toll-free in Canada, at 1-833-201-4358 |TTY: 1-866-694-8389, or send us your details and we’ll get back to you.

Looking to find all the other ways government can help you grow, scale or take it global? Check out to find the right supports for your business.